NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (”NeuroVive” or the ”Company”) has today decided upon a…
Continue Reading-
Themis and Institut Pasteur Join Coronavirus Vaccine Hunt
The Austrian biotech Themis — specializing in vaccines for infectious and insect-borne diseases — has…
Continue Reading